Company Search:
Advanced Search
Sponsored Links
Viatris Inc Company Snapshot
Viatris Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Viatris Inc with three other companies in this sector in UNITED STATES : Zoetis Inc (2020 sales of $6.68 billion of which 53% was US), Regeneron Pharmaceuticals Incorporated ($8.50 billion of which 58% was EYLEA), and Vertex Pharmaceuticals Inc ($6.21 billion of which 62% was TRIKAFTA).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Viatris Inc totalled $4.58 billion. This is an increase of 67.6% from the $2.73 billion in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled $9.01 billion, which is 68.4% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Viatris Inc were $11.95 billion. This is an increase of 3.9% versus 2019, when the company's sales were $11.50 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Viatris Inc
  Stock Performance Chart for Viatris Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/15/2021): 13.46
(Figures in U.S. Dollars)
1 Week -1.2%   13 Weeks -0.8%  
4 Weeks -2.2%   52 Weeks -14.3%  
Viatris Inc Key Data:
  Ticker: VTRS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 11,946,000,000
(Year Ending Jan 2021).
Employees: 45,000
  Currency: U.S. Dollars Market Cap: 16,275,998,069
  Fiscal Yr Ends: December Shares Outstanding: 1,209,212,338
  Share Type: Common Closely Held Shares: 5,184,553
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.